These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37940926)

  • 21. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.
    Loomba R; Schork N; Chen CH; Bettencourt R; Bhatt A; Ang B; Nguyen P; Hernandez C; Richards L; Salotti J; Lin S; Seki E; Nelson KE; Sirlin CB; Brenner D;
    Gastroenterology; 2015 Dec; 149(7):1784-93. PubMed ID: 26299412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
    Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
    Bril F; McPhaul MJ; Caulfield MP; Clark VC; Soldevilla-Pico C; Firpi-Morell RJ; Lai J; Shiffman D; Rowland CM; Cusi K
    Diabetes Care; 2020 Feb; 43(2):290-297. PubMed ID: 31604692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
    Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
    Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea.
    Lee HJ; Chang JS; Ahn JH; Kim MY; Park KS; Ahn YS; Koh SB
    J Prev Med Public Health; 2021 Nov; 54(6):412-421. PubMed ID: 34875824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
    Chen J; Allen AM; Therneau TM; Chen J; Li J; Hoodeshenas S; Chen J; Lu X; Zhu Z; Venkatesh SK; Song B; Ehman RL; Yin M
    Eur Radiol; 2022 Feb; 32(2):950-958. PubMed ID: 34432123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.
    Kim BK; Bernstein N; Huang DQ; Tamaki N; Imajo K; Yoneda M; Sutter N; Jung J; Nguyen K; Nguyen L; Le T; Madamba E; Richards L; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R
    Aliment Pharmacol Ther; 2023 Jul; 58(2):229-237. PubMed ID: 37269117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.
    Yu NY; Wolfson T; Middleton MS; Hamilton G; Gamst A; Angeles JE; Schwimmer JB; Sirlin CB
    Clin Radiol; 2017 May; 72(5):425.e9-425.e14. PubMed ID: 28063601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
    Xia T; Du M; Li H; Wang Y; Zha J; Wu T; Ju S
    Radiology; 2023 Oct; 309(1):e231007. PubMed ID: 37874242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
    Bril F; Barb D; Lomonaco R; Lai J; Cusi K
    J Hepatol; 2020 Mar; 72(3):401-410. PubMed ID: 31589891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study.
    Mantovani A; Zusi C; Csermely A; Salvagno GL; Colecchia A; Lippi G; Maffeis C; Targher G
    Hormones (Athens); 2022 Sep; 21(3):477-486. PubMed ID: 35831700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
    Dioguardi Burgio M; Sartoris R; Beaufrere A; Grégory J; Guiu B; Guillot C; Rautou PE; Castera L; Bouattour M; Paradis V; Vilgrain V; Ronot M
    Eur Radiol; 2022 Mar; 32(3):1781-1791. PubMed ID: 34533606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.
    Tamaki N; Ajmera V; Loomba R
    Nat Rev Endocrinol; 2022 Jan; 18(1):55-66. PubMed ID: 34815553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
    Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
    J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis.
    Andersson A; Kelly M; Imajo K; Nakajima A; Fallowfield JA; Hirschfield G; Pavlides M; Sanyal AJ; Noureddin M; Banerjee R; Dennis A; Harrison S
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2451-2461.e3. PubMed ID: 34626833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study.
    Seeberg KA; Hofsø D; Borgeraas H; Grimnes JO; Fatima F; Seeberg LT; Kvan NP; Svanevik M; Hertel JK; Hjelmesæth J
    BMC Gastroenterol; 2022 Nov; 22(1):448. PubMed ID: 36336684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes.
    Kuo SZ; Cepin S; Bergstrom J; Siddiqi H; Jung J; Lopez S; Huang DQ; Taub P; Amangurbanova M; Loomba R
    Aliment Pharmacol Ther; 2023 Sep; 58(6):585-592. PubMed ID: 37431679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.
    Corbin KD; Pittas AG; Desouza C; Grdinovac KK; Herzig KH; Kashyap SR; Kim SH; Nelson J; Rasouli N; Vickery EM; Knowler WC; Pratley RE
    J Diabetes Complications; 2023 Jun; 37(6):108475. PubMed ID: 37104979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.